US Patent Issued to HORIZON THERAPEUTICS IRELAND DAC on Aug. 19 for "Process of making a crystalline EDG-2 receptor antagonist" (Irish Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,640, issued on Aug. 19, was assigned to HORIZON THERAPEUTICS IRELAND DAC (Dublin).

"Process of making a crystalline EDG-2 receptor antagonist" was invented by Denis Billen (Dublin), Benedicte Martin (Dublin) and Michelle O'Mahony (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of making crystalline Form 1 of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid."

The patent was filed on March 1, 2023, under Application No. 18/176,862.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...